NASDAQ:MLND

Millendo Therapeutics (MLND) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$3.24
$3.47
50-Day Range
$3.06
$5.84
52-Week Range
$0.92
$16.95
Volume
400,752 shs
Average Volume
1.52 million shs
Market Capitalization
$65.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MLND stock logo

About Millendo Therapeutics Stock (NASDAQ:MLND)

As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.

MLND Stock News Headlines

Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)
Expert Ratings for Decibel Therapeutics
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Clearmind Announces Pre-IND Meeting Date with FDA
See More Headlines
Receive MLND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Millendo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MLND
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Net Income
$-36,410,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.78 per share

Miscellaneous

Free Float
N/A
Market Cap
$65.13 million
Optionable
Not Optionable
Beta
0.48
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

MLND Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Millendo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Millendo Therapeutics investors own include Allena Pharmaceuticals (ALNA), Matinas BioPharma (MTNB), VYNE Therapeutics (VYNE), Acasti Pharma (ACST), Onconova Therapeutics (ONTX), TherapeuticsMD (TXMD), Bionano Genomics (BNGO), DURECT (DRRX), Geron (GERN) and Heat Biologics (HTBX).

This page (NASDAQ:MLND) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners